UNSPSC 51285306: Furalazine

This classification denotes an anti-infective agent with the molecular formula C9H7N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2133JVQ6VE, chemically known as 1,2,4-triazin-3-amine, 6-(2-(5-nitro-2-furanyl)ethenyl)- (9ci) but more generally known as furalazine, which bears US NIH Compound Identifier 6436102. European Medicines Agency schedules Furalazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07830MIG. The term FURALAZINE is an International Non-Proprietary Name.

UNSPSC 51285306 Furalazine is a Commodity code, but the recent state and local opportunities tagged under it show minimal genuine alignment with furalazine procurement itself. Instead, the code appears to be receiving miscellaneous health and pharmaceutical supply solicitations, including naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic pharmaceuticals through cooperative purchasing, and pharmacy benefit program management services. State and local issuing bodies posting under this code span county health departments (Seminole County, Florida), city fire and rescue divisions (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving multiple states including Oregon). The actual procurement focus is on emergency medical consumables, pharmaceutical products and delivery systems, and health program administration rather than the specific active pharmaceutical ingredient named in the code.

Geographic activity centers on Florida (Seminole County and Tampa), Texas, and Minnesota with multi-state reach through the MMCAP cooperative. Representative recent opportunities include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with a response deadline of July 26, 2023 and quarterly deliveries required; the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, due March 13, 2026, with an estimated contract value of $700,000 and a 5 percent bid discount set-aside for certified Small Local Business Enterprises; and Minnesota's MMCAP RFP for generic multi-source pharmaceuticals and OTC products across participating state and local facilities, due March 26, 2026, with contract effective July 1, 2026. The code shows active procurement but the mismatch between the nominal furalazine commodity and the actual solicitations posted suggests the code is either misconfigured in the tagging system or is serving as a catch-all for health-sector pharmaceutical and medical supply purchases that do not fit more specific categories.